|1.||Dralle, Henning: 21 articles (01/2015 - 01/2002)|
|2.||Machens, Andreas: 15 articles (01/2015 - 04/2005)|
|3.||Dralle, H: 12 articles (09/2015 - 01/2000)|
|4.||Elisei, Rossella: 11 articles (01/2014 - 01/2004)|
|5.||Thomas, Shibu: 10 articles (01/2016 - 09/2005)|
|6.||Niederle, Bruno: 10 articles (02/2014 - 04/2002)|
|7.||Müller, Beat: 10 articles (07/2013 - 10/2002)|
|8.||Becker, K L: 10 articles (04/2004 - 04/2000)|
|9.||Shah, Girish V: 9 articles (01/2016 - 05/2005)|
|10.||Giovanella, Luca: 9 articles (01/2016 - 05/2009)|
09/01/1994 - "Drugs that inhibit bone turnover, such as calcitonin, appear to be effective in increasing bone mass for 1.5 to 2 years, about the time it would take to replenish the remodeling space in a patient with high turnover osteoporosis. "
10/01/1987 - "This type of treatment regime, with its calcitonin-like effect, might be effective in reducing net bone loss due to imbalance between bone formation and resorption at the BMU level, particularly in patients with increased numbers of BMUs ('high turnover' osteoporosis).(ABSTRACT TRUNCATED AT 250 WORDS)"
11/01/1999 - "These results suggest that the therapeutic efficacy of BPs or calcitonin in diseases such as glucocorticoid-induced osteoporosis may be due, in part, to their ability to prevent osteocyte and osteoblast apoptosis."
06/07/1992 - "Intermittent administration of low-dose calcitonin, especially together with an anabolic steroid seems to be a safe and effective therapy in established osteoporosis."
01/01/2000 - "Efficacy of calcitonin for fracture prevention in steroid-induced osteoporosis remains to be established."
01/01/1982 - "One week after commencing therapy there was improvement or marked improvement of pain in significantly more patients in the calcitonin group (5/13) than in the placebo group (0/12) (Fisher's exact two-tailed probability test, P = 0.0484). "
01/01/2012 - "The combined results from 13 trials (n = 589) determined that calcitonin significantly reduced the severity of acute pain in recent OVCFs. "
10/01/2005 - "The combined results from five randomized controlled trials, involving 246 patients, determined that calcitonin significantly reduced the severity of pain using a visual analogue scale following diagnosis. "
04/01/2003 - "Thirteen of these studies demonstrated statistically significant improvement in pain or function in calcitonin-treated patients. "
01/01/2015 - "This meta-analysis suggest that calcitonin provide no significant improvement in pain symptoms or walking distance in LSS patients."
|3.||Hypercalcemia (Milk Alkali Syndrome)
11/01/2011 - "After forced hydration and administration of furocemide and calcitonin, hypercalcemia was improved. "
02/01/1970 - "Importance of endogenous thyrocalcitonin for protection against hypercalcemia in the rat."
01/01/2006 - "The conflicting results of previous evaluations of the influence of hypercalcemia on thyroid C-cells and the absence of reports on its influence on calcitonin (CT)-producing cells of the airways prompted this study. "
01/01/1979 - "Studies of calcitonin cells and parathyroid gland of house shrew, Suncus murinus in response to experimental hypercalcemia."
04/01/2015 - "Calcitonin has an immediate effect on decreasing osteoclast activity and has been used for treatment of hypercalcemia. "
01/01/1990 - "Progress in the knowledge of the disease has recently been obtained in the following ways: the IRMA assay of mature calcitonin, the disease marker, has permitted earlier diagnosis of familial cases and recurrence; the locus assignment of the gene on chromosome 10 now enables a valid discrimination in certain families of gene carriers; collaborative clinical, biological, pathological, therapeutic and epidemiological research on a nation-wide scale has had a beneficial effect on patients, with improvement in diagnosis of the familial forms, in disease prognosis, in cancer detection at an infraclinical stage, and in the regrouping and distribution of families in France."
03/01/2007 - "Tissue-specific expression of the promoter for calcitonin and calcitonin-related polypeptide alpha has allowed therapeutic genes to be specifically expressed in calcitonin-secreting cells and in the MTC tumors derived from them; such tissue-specific expression contributes to improved safety of gene therapies and has the potential to increase their therapeutic index. "
08/01/1995 - "We have measured SRIF plasma levels in 35 patients with different stages of MTC to evaluate the use of SRIF as a plasma tumor marker compared to the current "gold standard" calcitonin (CT). "
07/01/2007 - "In this study, we propose calcitonin measurement in the washout of FNAB needles after sampling each tumor (FNAB-CT) as a new approach to diagnosis of MTC. "
01/01/2007 - "In addition to RET, an old marker, calcitonin, has assumed increasing importance, but may not adequately reflect changes in tumor burden in RET inhibitor trials. "
|5.||Neoplasm Metastasis (Metastasis)
04/01/2005 - "On multivariate analysis, preoperative basal calcitonin levels greater than 500 pg/ml best predicted the failure to achieve biochemical remission, followed by nodal metastasis and reoperative status. "
01/01/2006 - "There was no evidence that calcitonin was effective in controlling complications due to bone metastases; for improving quality of life; or patients' survival. "
01/01/2003 - "There was no evidence that calcitonin was effective in controlling complications due to bone metastases; for improving quality of life; or patients' survival. "
04/01/2005 - "Node-positive patients did not achieve biochemical remission when their preoperative basal calcitonin levels exceeded 3000 pg/ml. Nodal metastasis started emerging at basal calcitonin levels of 10-40 pg/ml (normal range, <10 pg/ml). "
09/01/2010 - "Initially the study involved eight patients with MTC and elevated basal or stimulated calcitonin, in which earlier diagnostic imaging was negative for metastasis: neck ultrasound, chest and mediastinal CT scan, liver MRI, bone scintigraphy, and ¹⁸F-FDG-PET. "
|4.||Alendronate (Alendronate Sodium)
|6.||Etidronic Acid (HEDP)
|7.||Parathyroid Hormone (Parathormone)
|10.||Adrenocorticotropic Hormone (ACTH)
|2.||Hormone Replacement Therapy (Therapy, Hormone Replacement)